FDA approves FreeStyle Libre Pro system, a continuous glucose monitoring (CGM) system.Abbott

Abbott has announced that the FDA has approved the company's FreeStyle Libre Pro system, a revolutionary continuous glucose monitoring (CGM) system for healthcare professionals to use with their patients with diabetes. FreeStyle Libre Pro system is designed to empower healthcare professionals to provide better diabetes management for diabetes patients. The system provides healthcare professionals with a visual snapshot of glucose data, known as the Ambulatory Glucose Profile (AGP), giving a more simplified and clear overview of not only glucose levels, but also patterns and trends within those levels. This valuable information helps healthcare professionals make better, customized treatment decisions for their patients � and for a significantly lower cost than other professional CGM products available.

Abbott recently submitted the consumer version of the FreeStyle Libre system for review by the FDA. The consumer version of the FreeStyle Libre system is designed to be a continuous glucose monitoring system that does not require fingerstick calibration, and measures glucose levels through a small sensor on the back of the upper arm for up to 14 days. Patients can self-monitor their glucose levels by scanning a reader over the sensor as often as desired to get a reading.

Abbott's FreeStyle Libre Pro system has a number of key advantages compared to other professional CGM systems, including: �Convenient for both the doctor and the patient. With the FreeStyle Libre Pro system there is no requirement for fingerstick calibration so patients do not need to be trained by their healthcare professional on calibration. After the sensor is applied to the patient, there is no requirement for the patient to interact with the system. �Provides reliable glucose data. Healthcare professionals receive up to 14 days of continuous glucose data based on uninterrupted, normal daily routines of their patients. �Reduce equipment costs, maintenance and time. FreeStyle Libre Pro system costs significantly less than other professional CGM products on the market. The doctor's office only needs to purchase one FreeStyle Libre Pro reader for multiple patients without having to spend on extra recorders, receivers and transmitters, or devote time to routine disinfecting or recharging patient use components. In addition to the glucose sensor, other professional CGM systems require reusable hardware components, such as receivers, transmitters, and recorders that must go home with each patient to perform the professional CGM assessment.